3SBio Inc. (HKG:1530)
Hong Kong
· Delayed Price · Currency is HKD 17.50
+1.59 (9.99%)
Jun 29, 2026, 11:59 AM HKT
3SBio Employees
3SBio had 6,109 employees as of December 31, 2025. The number of employees increased by 532 or 9.54% compared to the previous year.
Employees
6,109
Change (1Y)
532
Growth (1Y)
9.54%
Revenue / Employee
3.22M HKD
Profits / Employee
1.55M HKD
Market Cap
39.79B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 1,443 |
| Shanghai Junshi Biosciences | 2,903 |
| Shanghai Henlius Biotech | 3,762 |
| RemeGen | 3,048 |
| Genscript Biotech | 6,165 |
| InnoCare Pharma | 1,176 |
| Sino Biopharmaceutical | 21,435 |
| Akeso | 3,761 |
3SBio News
- 3 months ago - 3SBio Earnings release: H2 2025 - Filings
- 3 months ago - 3SBio Annual report: H2 2025 - Filings
- 10 months ago - 3SBio Quarterly report: H1 2025 - Filings
- 10 months ago - 3SBio Earnings release: H1 2025 - Filings
- 1 year ago - Pfizer Signs $6B Deal with 3SBio for China-Based Cancer Drug - TipRanks